Biofrontera
BFRI
14 hedge funds and large institutions have $729K invested in Biofrontera in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 3
0.03% less ownership
Funds ownership: 0.18% → 0.15% (-0.03%)
13% less funds holding
Funds holding: 16 → 14 (-2)
17% less capital invested
Capital invested by funds: $881K → $729K (-$152K)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.27K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.6K |
| 3 |
Renaissance Technologies
New York
|
+$6.13K |
| 4 |
QC
Quent Capital
New York
|
+$1.82K |
| 5 |
BlackRock
New York
|
+$1.43K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
-$56.2K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$5K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.51K |
| 4 |
Jane Street
New York
|
-$4.11K |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$19 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Vanguard Group
Malvern,
Pennsylvania
| $201K | +$6.6K | +323 | +3% |
|
|
BA
2
Bard Associates
Chicago,
Illinois
| $182K | -$56.2K | -2,754 | -22% |
|
|
3
BlackRock
New York
| $110K | +$1.43K | +70 | +1% |
|
|
SSA
4
Schonfeld Strategic Advisors
New York
| $84.1K | +$408 | +20 | +0.4% |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $76K | +$9.27K | +454 | +12% |
|
6
State Street
Boston,
Massachusetts
| $21K | – | – | – |
|
7
Northern Trust
Chicago,
Illinois
| $19K | – | – | – |
|
|
8
Renaissance Technologies
New York
| $18K | +$6.13K | +300 | +43% |
|
|
9
Jane Street
New York
| $10.1K | -$4.11K | -201 | -27% |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $4K | -$4.51K | -221 | -51% |
|
11
Osaic Holdings
Scottsdale,
Arizona
| $3K | – | – | – |
|
|
QC
12
Quent Capital
New York
| $1.64K | +$1.82K | +89 | New |
|
13
Wells Fargo
San Francisco,
California
| $110 | +$20 | +1 | +20% |
|
14
Bank of America
Charlotte,
North Carolina
| $32 | +$41 | +2 | New |
|
|
15
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$19 | -750 | Closed |
|
|
16
UBS Group
Zurich,
Switzerland
| – | -$5K | -237 | Closed |
|
BFRI Hedge Fund Activity: Q4 2022 in Review
14 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRI) for Q4 2022, worth a combined $729K — down 17% from $881K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of BFRI and 2 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 6 added.
The largest buyer was Geode Capital Management, adding an estimated $9.27K. The largest seller was Bard Associates, cutting an estimated $56.2K.
- 14 institutional investors held Biofrontera (BFRI) as of Q4 2022, down from 16 in Q3 2022.
- Funds reported $729K of Biofrontera stock for Q4 2022, down 17% quarter-over-quarter.
- 2 funds opened new Biofrontera positions in Q4 2022 and 4 closed out, a net change of -2 holders.
- The largest Biofrontera buyer in Q4 2022 was Geode Capital Management, an estimated $9.27K added.
- The largest Biofrontera seller in Q4 2022 was Bard Associates, an estimated $56.2K sold.
Based on aggregated 13F filings for Q4 2022.